Instrument control and data acquisition was achieved via LabSolutions software (Shimadzu Corporation, Kyoto, Japan)
This has prompted adaptations in the food sector and significant shifts in the weight loss industry
Although Hims & Hers relationship with Novo may have ended, the company has an existing partnership 3 with Eli Lilly, in which they are permitted to sell Zepbound, a GLP-1 approved by the FDA for weight loss, and Mounjaro, which is not approved for weight loss but for the treatment of type 2 diabetes
Its effects include reducing energy intake, suppressing hunger, and promoting satiety (36, 37)
Recent studies have uncovered increased DPP-4 expression and secretion from hepatocytes in obese mice, with a DPP-4 expression and activity much higher in the liver than in adipose tissue, indicating its emerging role as a hepatokine in the interplay between hepatocytes and adipocytes [4]